State of Wisconsin Investment Board’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,242
Closed -$30K 2306
2024
Q2
$30K Buy
2,242
+156
+7% +$4.65K ﹤0.01% 2272
2024
Q1
$96.8K Sell
2,086
-382
-15% -$19.8K ﹤0.01% 2131
2023
Q4
$167K Sell
2,468
-404
-14% -$24.7K ﹤0.01% 2226
2023
Q3
$208K Buy
2,872
+1,010
+54% +$80.7K ﹤0.01% 2224
2023
Q2
$139K Sell
1,862
-776
-29% -$45.9K ﹤0.01% 2197
2023
Q1
$140K Buy
2,638
+80
+3% +$5.07K ﹤0.01% 2338
2022
Q4
$173K Sell
2,558
-229
-8% -$21.1K ﹤0.01% 2271
2022
Q3
$348K Sell
2,787
-965
-26% -$115K ﹤0.01% 2146
2022
Q2
$357K Buy
+3,752
New +$458K ﹤0.01% 2241

Other funds holding DNA

State of Wisconsin Investment Board's DNA Position: Q3 2024 in Review

State of Wisconsin Investment Board sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 2,242 shares — an estimated $30K sold.

State of Wisconsin Investment Board first reported a position in DNA in Q2 2022 and held it in 9 quarters. The position peaked at $357K in Q2 2022. 158 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • State of Wisconsin Investment Board reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 2,242 Ginkgo Bioworks shares in Q3 2024, an estimated $30K.
  • State of Wisconsin Investment Board first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 9 quarters.
  • State of Wisconsin Investment Board's Ginkgo Bioworks position peaked at $357K in Q2 2022.
  • 158 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2024, filed 14 Nov 2024.